Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit
Samir Gupta, Gloria D. Coronado, Keith Argenbright, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 4, pp. 283-298
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer
Andrea N. Burnett‐Hartman, Jeffrey K. Lee, Joshua Demb, et al.
Gastroenterology (2021) Vol. 160, Iss. 4, pp. 1041-1049
Open Access | Times Cited: 218
Changes in Cancer Screening in the US During the COVID-19 Pandemic
Stacey A. Fedewa, Jessica Star, Priti Bandi, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215490-e2215490
Open Access | Times Cited: 125
Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region
Han‐Mo Chiu, Chiu-Wen Su, Weng-Feng Hsu, et al.
Preventive Medicine (2021) Vol. 151, pp. 106622-106622
Open Access | Times Cited: 114
An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer
Doaa Fathi, Mohammed S. Elballal, Ahmed E. Elesawy, et al.
Life Sciences (2023) Vol. 322, pp. 121667-121667
Closed Access | Times Cited: 53
A review of the biological role of miRNAs in prostate cancer suppression and progression
Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, et al.
International Journal of Biological Macromolecules (2021) Vol. 197, pp. 141-156
Closed Access | Times Cited: 89
A fluorescence switch-off nanosensor for sensitive determination of the antiandrogen drug flutamide in pharmaceutical and environmental samples. Analytical method greenness, blueness, and whiteness assessment
Walaa Nabil Abd‐AlGhafar, Rasha Abo Shabana, Rania El‐Shaheny, et al.
Microchemical Journal (2024) Vol. 204, pp. 111078-111078
Closed Access | Times Cited: 14
Comprehensive Review on the Effect of Stem Cells in Cancer Progression
Subhadeep Das, Tabish Khan, Debasish Sarkar
Current Tissue Microenvironment Reports (2024) Vol. 5, Iss. 2, pp. 39-59
Closed Access | Times Cited: 13
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
Alessandro Mannucci, Ajay Goel
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Mailed Outreach and Patient Navigation for Colorectal Cancer Screening Among Rural Medicaid Enrollees
Gloria D. Coronado, Amanda F. Petrik, Michael C. Leo, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250928-e250928
Open Access | Times Cited: 1
Colorectal Cancer Screening and Prevention in the COVID-19 Era
Rachel B. Issaka, Ma Somsouk
JAMA Health Forum (2020) Vol. 1, Iss. 5, pp. e200588-e200588
Open Access | Times Cited: 56
Screening for Colorectal Cancer in the United States: Correlates and Time Trends by Type of Test
Jean A. Shapiro, Ashwini Soman, Zahava Berkowitz, et al.
Cancer Epidemiology Biomarkers & Prevention (2021) Vol. 30, Iss. 8, pp. 1554-1565
Open Access | Times Cited: 47
Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic
Rachel B. Issaka, Preston Taylor, Anand Baxi, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e216454-e216454
Open Access | Times Cited: 42
Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signaling
Amar Ajmal, Yasir Ali, Ajmal Khan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 18, pp. 8866-8875
Closed Access | Times Cited: 29
The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities
Jesse Nodora, Samir Gupta, Nicole Howard, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 8, pp. 962-968
Open Access | Times Cited: 50
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)
Hongda Chen, Jufang Shi, Ming Lu, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 3, pp. 808-818
Open Access | Times Cited: 28
Colonoscopy vs the Fecal Immunochemical Test: Which is Best?
Douglas J. Robertson, Douglas K. Rex, Oriana Ciani, et al.
Gastroenterology (2024) Vol. 166, Iss. 5, pp. 758-771
Closed Access | Times Cited: 5
Barriers to utilization of three colorectal cancer screening options – Data from a national survey
Xuan Zhu, Philip D. Parks, Emily L. Weiser, et al.
Preventive Medicine Reports (2021) Vol. 24, pp. 101508-101508
Open Access | Times Cited: 30
Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing
Gregory S. Cooper, Ashley Grimes, James J. Werner, et al.
The Journal of the American Board of Family Medicine (2021) Vol. 34, Iss. 1, pp. 61-69
Open Access | Times Cited: 29
Screening and Surveillance Colonoscopy and COVID-19: Avoiding More Casualties
Samir Gupta, David A. Lieberman
Gastroenterology (2020) Vol. 159, Iss. 4, pp. 1205-1208
Open Access | Times Cited: 29
Early colorectal cancer detection—Current and evolving challenges in evidence, guidelines, policy, and practices
Robert A. Smith, Stacey A. Fedewa, Rebecca L. Siegel
Advances in cancer research (2021), pp. 69-107
Closed Access | Times Cited: 24
The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach
Emilia Bevacqua, Salvatore Ammirato, Erika Cione, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5418-5418
Open Access | Times Cited: 19
Cost-Effectiveness of Noninvasive Colorectal Cancer Screening in Community Clinics
Pedro Nascimento de Lima, Laura Matrajt, Gloria D. Coronado, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2454938-e2454938
Open Access
Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study
Tami Gurley, Rubén Hernáez, Vanessa Cerda, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103113-103113
Closed Access
Perceptions and Attitudes Toward Utilizing a Non‐Invasive Biomarker for Colorectal Cancer Screening: A Qualitative Study
Chien-Wei Chu, Junjie Huang, Jamie Jie Mei Liew, et al.
Cancer Reports (2025) Vol. 8, Iss. 4
Open Access
The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System
Andrew J. Gawron, Tonya Kaltenbach, Jason A. Dominitz
Gastroenterology (2020) Vol. 159, Iss. 4, pp. 1216-1220.e1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top